CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 1,586 enrolled
Drug / intervention
Laerdal Q-CPR /technologyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00539539
NCT00539539Phase 2Completed
CompareCT.gov

Controlled Study of the Clinical Effectiveness of Automated Real-Time Feedback on CPR Process Conducted at a Subset of ROC Sites

University of Washington·interventional·Posted Oct 4, 2007·Updated Jun 25, 2012

In Brief

A Phase 2 clinical trial evaluating Laerdal Q-CPR /technology for Heart Arrest. Completed, enrolled 1,586 participants across 3 sites in 2 countries.

Detailed Summary

The purpose of this study is to evaluate whether or not real-time feedback on CPR process variables will increase rates of restoration of spontaneous circulation during prehospital resuscitation and upon arrival at the receiving emergency room as well as increase rates of survival to hospital discharge.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Arrest
CountriesCanada, United States
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI), National Institute of Neurological Disorders and Stroke (NINDS), The Institute of Circulatory and Respiratory Health (ICRH), Defence Research and Development Canada

Timeline

Phase 2CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 4, 2007
Enrollment StartFeb 1, 2007
Primary CompletionJun 1, 2009
Study CompletionSep 1, 2009
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 18.7 years ago

Interventions

Laerdal Q-CPR /technologyother

For the first three to six months, participating EMS agencies will have defibrillators with automated, real-time feedback inactivated. During this period, the baseline rate of ROSC (and secondary outcomes) will be collected. At the end of this baseline period, EMS agencies will be randomized to one of two interventions, with randomization stratified within site by agency, station, or device. All clusters will cross-over to the opposite feedback strategy at least once during the intervention phase.